Article
Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer.
BMC cancer - 6 Jun 2016
Tominaga Tetsuro, Tsuchiya Tomoshi, Mochinaga Koji, Arai Junichi, Yamasaki Naoya, Matsumoto Keitaro, Miyazaki Takuro, Nagasaki Toshiya, Nanashima Atsushi, Tsukamoto Kazuhiro, Nagayasu Takeshi
Abstract excerpt
BACKGROUND: It has been shown that epidermal growth factor receptor (EGFR) mutation status is associated with 5-fluorouracil (5-FU) sensitivity in non-small-cell lung cancer (NSCLC). However, the relationship between EGFR mutation status and dihydropyrimidine dehydrogenase (DPD), a 5-FU degrading enzyme, is unknown. METHODS: We elucidated the crosstalk among the EGFR signal cascade, the DPD gene (DPYD), and DPD...
Topics
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Cell Survival
- Dihydrouracil Dehydrogenase (NADP)
- Drug Resistance, Neoplasm
- Drug Synergism
- Epidermal Growth Factor
- ErbB Receptors
- Fluorouracil
